Annual EBIT
-$1.83 M
-$1.80 M-5071.47%
December 31, 2023
Summary
- As of February 10, 2025, BLACU annual earnings before interest & taxes is -$1.83 million, with the most recent change of -$1.80 million (-5071.47%) on December 31, 2023.
- During the last 3 years, BLACU annual EBIT has risen by +$13.56 million (+88.10%).
- BLACU annual EBIT is now -55375.76% below its all-time high of -$3300.00, reached on December 1, 2021.
Performance
BLACU EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$454.10 K
+$21.40 K+4.50%
September 30, 2024
Summary
- As of February 10, 2025, BLACU quarterly earnings before interest & taxes is -$454.10 thousand, with the most recent change of +$21.40 thousand (+4.50%) on September 30, 2024.
- Over the past year, BLACU quarterly EBIT has dropped by -$3300.00 (-0.73%).
- BLACU quarterly EBIT is now -454000.00% below its all-time high of -$100.00, reached on September 1, 2021.
Performance
BLACU Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$2.24 M
-$43.70 K-1.99%
September 30, 2024
Summary
- As of February 10, 2025, BLACU TTM earnings before interest & taxes is -$2.24 million, with the most recent change of -$43.70 thousand (-1.99%) on September 30, 2024.
- Over the past year, BLACU TTM EBIT has dropped by -$238.90 thousand (-11.92%).
- BLACU TTM EBIT is now -149386.67% below its all-time high of -$1500.00, reached on June 1, 2022.
Performance
BLACU TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
BLACU EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -5071.5% | -0.7% | -11.9% |
| 3 y3 years | +88.1% | -0.7% | -11.9% |
| 5 y5 years | +93.4% | -0.7% | -11.9% |
BLACU EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | <-9999.0% | +47.3% | <-9999.0% | at low |
| 5 y | 5-year | <-9999.0% | +91.6% | <-9999.0% | +47.3% | <-9999.0% | at low |
| alltime | all time | <-9999.0% | +95.1% | <-9999.0% | +47.3% | <-9999.0% | at low |
Bellevue Life Sciences Acquisition EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$454.10 K(-4.5%) | -$2.24 M(+2.0%) |
| Jun 2024 | - | -$475.50 K(+5.5%) | -$2.20 M(+9.7%) |
| Mar 2024 | - | -$450.80 K(-47.7%) | -$2.00 M(+9.4%) |
| Dec 2023 | -$1.83 M(+5071.5%) | -$861.90 K(+110.0%) | -$1.83 M(+86.2%) |
| Sep 2023 | - | -$410.40 K(+46.4%) | -$983.10 K(+65.9%) |
| Jun 2023 | - | -$280.30 K(+0.8%) | -$592.70 K(+89.1%) |
| Mar 2023 | - | -$278.10 K(+1844.8%) | -$313.40 K(+785.3%) |
| Dec 2022 | -$35.40 K | - | - |
| Dec 2022 | - | -$14.30 K(-28.5%) | -$35.40 K(+65.4%) |
| Sep 2022 | - | -$20.00 K(+1900.0%) | -$21.40 K(+1326.7%) |
| Jun 2022 | - | -$1000.00(+900.0%) | -$1500.00(-53.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$100.00(-66.7%) | -$3200.00(+3.2%) |
| Dec 2021 | -$3300.00(-100.0%) | -$300.00(+200.0%) | -$3100.00(+10.7%) |
| Sep 2021 | - | -$100.00(-96.3%) | -$2800.00(+3.7%) |
| Jun 2021 | - | -$2700.00 | -$2700.00 |
| Dec 2020 | -$15.39 M(-29.3%) | - | - |
| Dec 2019 | -$21.77 M(-21.4%) | - | - |
| Dec 2018 | -$27.70 M(-26.1%) | - | - |
| Dec 2017 | -$37.48 M(+10.5%) | - | - |
| Dec 2016 | -$33.93 M(-2.5%) | - | - |
| Dec 2015 | -$34.81 M(+91.5%) | - | - |
| Dec 2014 | -$18.18 M | - | - |
FAQ
- What is Bellevue Life Sciences Acquisition annual earnings before interest & taxes?
- What is the all time high annual EBIT for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition annual EBIT year-on-year change?
- What is Bellevue Life Sciences Acquisition quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition quarterly EBIT year-on-year change?
- What is Bellevue Life Sciences Acquisition TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Bellevue Life Sciences Acquisition?
- What is Bellevue Life Sciences Acquisition TTM EBIT year-on-year change?
What is Bellevue Life Sciences Acquisition annual earnings before interest & taxes?
The current annual EBIT of BLACU is -$1.83 M
What is the all time high annual EBIT for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high annual earnings before interest & taxes is -$3300.00
What is Bellevue Life Sciences Acquisition annual EBIT year-on-year change?
Over the past year, BLACU annual earnings before interest & taxes has changed by -$1.80 M (-5071.47%)
What is Bellevue Life Sciences Acquisition quarterly earnings before interest & taxes?
The current quarterly EBIT of BLACU is -$454.10 K
What is the all time high quarterly EBIT for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high quarterly earnings before interest & taxes is -$100.00
What is Bellevue Life Sciences Acquisition quarterly EBIT year-on-year change?
Over the past year, BLACU quarterly earnings before interest & taxes has changed by -$3300.00 (-0.73%)
What is Bellevue Life Sciences Acquisition TTM earnings before interest & taxes?
The current TTM EBIT of BLACU is -$2.24 M
What is the all time high TTM EBIT for Bellevue Life Sciences Acquisition?
Bellevue Life Sciences Acquisition all-time high TTM earnings before interest & taxes is -$1500.00
What is Bellevue Life Sciences Acquisition TTM EBIT year-on-year change?
Over the past year, BLACU TTM earnings before interest & taxes has changed by -$238.90 K (-11.92%)